Premalignant lesions and gastric cancer: Current understanding

doi:10.4251/wjgo.v11.i9.665

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 9

This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12704)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

1023

WORD

263

HTML

7839

Figures (1-3)

441

Sum=9566

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

582

Download

641

Sum=1223

Publishing Process of This Article

Item

Count

Browse

821

Download

1094

Sum=1915

Sep 15, 2019 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (41)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Sep 15, 2019; 11(9): 665-678
Published online Sep 15, 2019. doi: 10.4251/wjgo.v11.i9.665

Full Size Figure Download Figure

Figure 3 Summary of the cellular and molecular events associated with progression to cancer. H. pylori: Helicobacter pylori; EBV: Epstein Barr virus positive; MSI: Microsatellite unstable; CagA: Cytotoxin-associated gene A protein; IM: Intestinal metaplasia; GS: Genomically stable.

Citation: Koulis A, Buckle A, Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J Gastrointest Oncol 2019; 11(9): 665-678
URL: https://www.wjgnet.com/1948-5204/full/v11/i9/665.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i9.665